Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2386]

MYSTIC interim results: any future for tremelimumab?

MYSTIC interim results: any future for tremelimumab?

Failure of retinoic acid trials against breast cancer explained

Failure of retinoic acid trials against breast cancer explained

Results of NRG-RTOG 0436 highlight need for biomarkers in treatment of oesophageal cancer

Results of NRG-RTOG 0436 highlight need for biomarkers in treatment of oesophageal cancer

Scientists shed new light on mechanism behind radiation bystander effect

Scientists shed new light on mechanism behind radiation bystander effect

Study demonstrates paclitaxel treatment promotes breast cancer dissemination and metastasis

Study demonstrates paclitaxel treatment promotes breast cancer dissemination and metastasis

Low doses of radiation could harm cardiovascular health, study suggests

Low doses of radiation could harm cardiovascular health, study suggests

New cancer treatments linked to cardiovascular alterations

New cancer treatments linked to cardiovascular alterations

Lymph node metastases may not always be the source of cancer's spread to other organs

Lymph node metastases may not always be the source of cancer's spread to other organs

Antibody appears to re-activate immune system in cancer therapy

Antibody appears to re-activate immune system in cancer therapy

Ribociclib receives positive CHMP opinion as first-line treatment for HR /HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor

Ribociclib receives positive CHMP opinion as first-line treatment for HR /HER2- locally advanced or metastatic...

More from ecancer